Working… Menu

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer (THREAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03825289
Recruitment Status : Recruiting
First Posted : January 31, 2019
Last Update Posted : November 13, 2020
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Utah

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 18, 2024
Estimated Study Completion Date : January 18, 2025